Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 71.75B | 73.25B | 63.12B | 65.08B | 62.67B | 59.14B |
Gross Profit | 17.80B | 18.24B | 13.15B | 12.96B | 15.72B | 15.18B |
EBITDA | 7.75B | 8.68B | 5.85B | 3.83B | 8.21B | 7.95B |
Net Income | 2.84B | 2.58B | 1.17B | -407.00M | 2.49B | 2.56B |
Balance Sheet | ||||||
Total Assets | 94.35B | 97.11B | 94.54B | 85.03B | 86.47B | 85.03B |
Cash, Cash Equivalents and Short-Term Investments | 12.69B | 16.75B | 16.13B | 9.13B | 12.22B | 11.60B |
Total Debt | 29.34B | 31.35B | 35.14B | 32.47B | 30.87B | 32.10B |
Total Liabilities | 51.50B | 52.60B | 53.24B | 46.73B | 46.09B | 47.63B |
Stockholders Equity | 37.83B | 38.73B | 36.75B | 34.35B | 36.77B | 34.65B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.39B | 4.59B | -2.11B | 2.86B | 557.00M |
Operating Cash Flow | 0.00 | 7.53B | 7.09B | 724.00M | 5.52B | 4.96B |
Investing Cash Flow | 0.00 | -2.14B | -2.01B | -2.88B | -2.70B | -3.80B |
Financing Cash Flow | 0.00 | -5.04B | 1.65B | -1.03B | -2.34B | 255.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥37.44B | 15.90 | 4.67% | 13.35% | 36.31% | ||
75 Outperform | ¥35.37B | 11.98 | 2.65% | -0.44% | 11.34% | ||
74 Outperform | ¥33.29B | 3.55 | 4.17% | 0.79% | 104.86% | ||
73 Outperform | ¥23.96B | 7.34 | 3.07% | 9.75% | 28.00% | ||
72 Outperform | ¥28.50B | 11.32 | 2.04% | 15.27% | 48.08% | ||
69 Neutral | ¥39.97B | 14.54 | 0.51% | 16.06% | 120.22% | ||
62 Neutral | $10.29B | 9.96 | -0.15% | 2.86% | 2.14% | -32.15% |
DKS Co., Ltd. has announced the disposal of 5,901 shares of its treasury stock under a Restricted Stock Compensation Plan, as resolved by its Board of Directors. This move is part of a broader strategy to align the interests of its directors and supervisory board members with those of its shareholders, facilitating the achievement of targets set in its medium-term management plan, SMART 2030.
DKS Co., Ltd. has announced a proposal to amend its Articles of Incorporation to include agricultural products as part of its business objectives. This strategic move aims to strengthen its Life & Wellness business and promote new business development to address social issues, potentially enhancing its market position and offering new opportunities for stakeholders.
DKS Co., Ltd. reported a significant increase in its financial performance for the fiscal year ended March 31, 2025, with net sales rising by 16.1% and operating income surging by 157.6%. This growth reflects the company’s strong market positioning and effective operational strategies, potentially benefiting stakeholders through increased dividends and a positive outlook for the upcoming fiscal year.
DKS Co., Ltd. announced an extraordinary loss due to an impairment loss of ¥365 million on fixed assets held by its subsidiary, IKEDA YAKUSOU Co., Ltd., for the fourth quarter of the fiscal year ending March 31, 2025. This financial adjustment reflects the company’s adherence to the Accounting Standard for Impairment of Fixed Assets, impacting its financial results for the period.